Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Nebraska
Adela, Inc
Case Comprehensive Cancer Center
Arcus Biosciences, Inc.
Universidade Federal de Pernambuco
Taproot Health
Cancer Support Community, Research and Training Institute, Philadelphia
Incyte Corporation
Shenzhen BinDeBio Ltd.
CureOne
SPGO Research Mannheim GmbH
M.D. Anderson Cancer Center
Stanford University
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
AstraZeneca